This common vaccine cuts heart risk nearly in half in new study
Why it matters: This common vaccine could offer a powerful, unexpected shield against heart attacks and strokes.
- Shingles vaccine dramatically cuts major cardiac events by 46% and deaths by 66% within one year for high-risk individuals.
- Scientists believe preventing shingles may also prevent clot-related complications that can lead to heart attacks and strokes.
- High-risk individuals stand to benefit significantly from this unexpected protective effect against cardiovascular disease.
A new study reveals that the common shingles vaccine could significantly reduce the risk of major cardiac events by 46% and deaths by 66% within a year for high-risk individuals. Scientists hypothesize that preventing shingles may also prevent clot-related complications that lead to heart attacks and strokes, suggesting a dual benefit for cardiovascular health.
